| TFV-H group (n = 120) | TFV-L group (n = 112) | p value | BMI-H group (n = 50) | BMI-L group (n = 182) | p value |
---|---|---|---|---|---|---|
Complications (Clavien–Dindo classification score ≥ 2) | 39 (32.5%) | 18 (16.1%) | 0.004 | 13 (26.0%) | 44 (24.1%) | 0.791 |
Severe complications (Clavien–Dindo classification score ≥ 3a) | 13 (10.8%) | 5 (4.5%) | 0.070 | 4 (8.0%) | 14 (7.7%) | 0.943 |
Pneumonia | 6 (5.0%) | 1 (0.9%) | 0.068 | 3 (6.0%) | 4 (2.2%) | 0.164 |
Anastomotic leakage | 7 (5.8%) | 3 (2.7%) | 0.237 | 2 (4.0%) | 8 (4.4%) | 0.902 |
Pancreatic fistula | 7 (5.8%) | 1 (0.9%) | 0.039 | 3 (6.0%) | 5 (2.8%) | 0.264 |
Incisional SSI | 3 (2.5%) | 6 (4.5%) | 0.413 | 1 (2.0%) | 7 (3.9%) | 0.526 |
Anastomotic stenosis | 3 (2.5%) | 0 (0.0%) | 0.092 | 0 (0.0%) | 3 (1.7%) | 0.361 |
Bleeding | 1 (0.8%) | 1 (0.9%) | 0.961 | 0 (0.0%) | 2 (1.1%) | 0.457 |
Bowel obstruction | 2 (1.7%) | 0 (0.0%) | 0.170 | 1 (2.0%) | 1 (0.6%) | 0.326 |
FUO | 2 (1.7%) | 1 (0.9%) | 0.602 | 1 (2.0%) | 2 (1.1%) | 0.617 |
Delayed gastric ejection | 3 (2.5%) | 3 (2.7%) | 0.932 | 0 (0.0%) | 6 (3.3%) | 0.193 |
Others | 8 (6.7%) | 3 (2.7%) | 0.153 | 2 (4.0%) | 9 (5.0%) | 0.781 |